X
20
Glenmark Life Sciences Limited Mumbai In, based in India, is a pharmaceutical company.
One of their significant offerings is Olmesartan medoxomil, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2016-111 - Rev 00
This Chemical Type CEP, issued on April 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2600 associated with this CEP further emphasizes